img

Global Immunocell Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Immunocell Therapy Market Research Report 2024

Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
According to MRAResearch’s new survey, global Immunocell Therapy market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Immunocell Therapy market research.
Key companies engaged in the Immunocell Therapy industry include Gilead Sciences and Novartis etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Immunocell Therapy were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Immunocell Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immunocell Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Gilead Sciences
Novartis
Segment by Type
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Immunocell Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2018-2033)
2.2 Immunocell Therapy Growth Trends by Region
2.2.1 Global Immunocell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immunocell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Immunocell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Immunocell Therapy Market Dynamics
2.3.1 Immunocell Therapy Industry Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunocell Therapy Players by Revenue
3.1.1 Global Top Immunocell Therapy Players by Revenue (2018-2023)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunocell Therapy Revenue
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2022
3.5 Immunocell Therapy Key Players Head office and Area Served
3.6 Key Players Immunocell Therapy Product Solution and Service
3.7 Date of Enter into Immunocell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2024-2033)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immunocell Therapy Market Size (2018-2033)
6.2 North America Immunocell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immunocell Therapy Market Size by Country (2018-2023)
6.4 North America Immunocell Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2018-2033)
7.2 Europe Immunocell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immunocell Therapy Market Size by Country (2018-2023)
7.4 Europe Immunocell Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunocell Therapy Market Size (2018-2033)
8.2 Asia-Pacific Immunocell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immunocell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunocell Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunocell Therapy Market Size (2018-2033)
9.2 Latin America Immunocell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immunocell Therapy Market Size by Country (2018-2023)
9.4 Latin America Immunocell Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunocell Therapy Market Size (2018-2033)
10.2 Middle East & Africa Immunocell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immunocell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunocell Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Detail
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Immunocell Therapy Introduction
11.1.4 Gilead Sciences Revenue in Immunocell Therapy Business (2018-2023)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Immunocell Therapy Introduction
11.2.4 Novartis Revenue in Immunocell Therapy Business (2018-2023)
11.2.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Others
Table 5. Global Immunocell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Immunocell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Immunocell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Immunocell Therapy Market Share by Region (2018-2023)
Table 9. Global Immunocell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Immunocell Therapy Market Share by Region (2024-2033)
Table 11. Immunocell Therapy Market Trends
Table 12. Immunocell Therapy Market Drivers
Table 13. Immunocell Therapy Market Challenges
Table 14. Immunocell Therapy Market Restraints
Table 15. Global Immunocell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Immunocell Therapy Market Share by Players (2018-2023)
Table 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2022)
Table 18. Ranking of Global Top Immunocell Therapy Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunocell Therapy Product Solution and Service
Table 22. Date of Enter into Immunocell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunocell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Immunocell Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Immunocell Therapy Revenue Market Share by Type (2024-2033)
Table 28. Global Immunocell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Immunocell Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Immunocell Therapy Revenue Market Share by Application (2024-2033)
Table 32. North America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Immunocell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Immunocell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Immunocell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Immunocell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Immunocell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Immunocell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Immunocell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Immunocell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Immunocell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Immunocell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Immunocell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Immunocell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 47. Gilead Sciences Company Detail
Table 48. Gilead Sciences Business Overview
Table 49. Gilead Sciences Immunocell Therapy Product
Table 50. Gilead Sciences Revenue in Immunocell Therapy Business (2018-2023) & (US$ Million)
Table 51. Gilead Sciences Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Immunocell Therapy Product
Table 55. Novartis Revenue in Immunocell Therapy Business (2018-2023) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunocell Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immunocell Therapy Market Share by Type: 2022 VS 2033
Figure 3. Chimeric Antigen Receptor (CAR) T Cell Therapy Features
Figure 4. Natural Killer (NK) Cell Therapy Features
Figure 5. Others Features
Figure 6. Global Immunocell Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Immunocell Therapy Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Immunocell Therapy Report Years Considered
Figure 12. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Immunocell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Immunocell Therapy Market Share by Region: 2022 VS 2033
Figure 15. Global Immunocell Therapy Market Share by Players in 2022
Figure 16. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunocell Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2022
Figure 18. North America Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Immunocell Therapy Market Share by Country (2018-2033)
Figure 20. United States Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Immunocell Therapy Market Share by Country (2018-2033)
Figure 24. Germany Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Immunocell Therapy Market Share by Region (2018-2033)
Figure 32. China Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Immunocell Therapy Market Share by Country (2018-2033)
Figure 40. Mexico Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Immunocell Therapy Market Share by Country (2018-2033)
Figure 44. Turkey Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Immunocell Therapy Business (2018-2023)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed